Mystic Asset Management Inc. Purchases New Stake in CVS Health Corporation $CVS

Mystic Asset Management Inc. acquired a new position in CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 30,357 shares of the pharmacy operator’s stock, valued at approximately $3,140,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd grew its stake in shares of CVS Health by 407.2% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 281 shares during the period. Swiss RE Ltd. acquired a new stake in shares of CVS Health in the fourth quarter valued at about $26,000. Kilter Group LLC purchased a new stake in CVS Health during the second quarter worth about $27,000. Sankala Group LLC acquired a new position in CVS Health during the fourth quarter worth about $28,000. Finally, Global Trust Asset Management LLC grew its position in CVS Health by 344.8% during the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 300 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Argus upped their price target on CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a report on Wednesday. Morgan Stanley lifted their price objective on CVS Health from $106.00 to $111.00 and gave the stock an “overweight” rating in a report on Thursday, June 4th. Barclays boosted their target price on CVS Health from $106.00 to $108.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Piper Sandler restated an “overweight” rating and issued a $113.00 price target on shares of CVS Health in a research report on Monday, June 1st. Finally, Sanford C. Bernstein boosted their price objective on shares of CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 12th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $107.17.

CVS Health Price Performance

CVS stock opened at $93.83 on Friday. The stock’s 50 day moving average price is $102.19 and its 200 day moving average price is $88.83. The firm has a market cap of $120.01 billion, a P/E ratio of 24.82, a PEG ratio of 0.89 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter last year, the business posted $1.81 earnings per share. CVS Health’s revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, sell-side analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.8%. CVS Health’s payout ratio is presently 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.